REMS

Recently the FDA issued final guidance on FDA’s application of the statutory factors in determining when a risk evaluation and…

After three years of work the Food and Drug Administration (FDA) released its final Risk Evaluation and Mitigation Strategies…

The Food and Drug Administration (FDA) released a “Blueprint for Prescriber Continuing Education Program” regarding the use of…

 The Accreditation Council of Continuing Medical Education (ACCME) announced a number of important topics in their recent August…

During last month’s Joint Meeting of the Anesthetic and Life Drugs Advisory Committee (ALSDAC) & Drug Safety and Risk…

As we noted last week, Murray Kopelow, M.D., M.S., Chief Executive and Secretary for the Accreditation Council for Continuing…

According to a FDA memo and recent article in the RPM Report, “continuing medical education (CME) has been under attack in…

The Food and Drug Administration (FDA) has acknowledged for years that "good medical practice and the best interests of the…

A new five-part Podcast series was recently announced by Med Ad News editors Steven Niles and Joshua Slatko. The series will…

The FDA today announced a Strategic Plan for Risk Communication that establishes a framework for communicating meaningful health…